The benefit of HER2-targeted therapies on overall survival of patients with metastatic HER2-positive breast cancer – a systematic review

INTRODUCTION: This study aimed at evaluating the overall survival (OS) gain associated with human epidermal growth factor receptor 2 (HER2)-directed therapies in patients with metastatic breast cancer (mBC). METHODS: A bibliographic search was conducted in PubMed and Cochrane databases. Only phase I...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Diogo, Alves, Carlos, Afonso, Noémia, Cardoso, Fátima, Passos-Coelho, José Luís, Costa, Luís, Andrade, Sofia, Batel-Marques, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650834/
https://www.ncbi.nlm.nih.gov/pubmed/26578067
http://dx.doi.org/10.1186/s13058-015-0648-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4650834/
https://www.ncbi.nlm.nih.gov/pubmed/26578067
http://dx.doi.org/10.1186/s13058-015-0648-2

Ejemplares similares